• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Nobel Biocare Holding AG

+ Add to Watchlist


16.900 CHF 0.050 0.29%

As of 08:50:21 ET on 10/24/2014.

Snapshot for Nobel Biocare Holding AG (NOBN)

Open: 16.950 Day's Range: 16.900 - 16.950 Volume: 205,190
Previous Close: 16.950 52wk Range: 11.850 - 18.450 1-Yr Rtn: +11.82%

Stock Chart for NOBN

No chart data available.
  • NOBN:SW 16.900
  • 1D
  • 1M
  • 1Y
Interactive NOBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOBN

Current P/E Ratio (ttm) 34.1768
Estimated P/E(12/2014) 32.7398
Relative P/E vs. SMI 1.7796
Earnings Per Share (EUR) (ttm) 0.4100
Est. EPS (EUR) (12/2014) 0.4280
Est. PEG Ratio 1.7724
Market Cap (M CHF) 2,091.96
Shares Outstanding (M) 123.78
30 Day Average Volume 1,616,969
Price/Book (mrq) 5.0433
Price/Sale (ttm) 3.0692
Dividend Indicated Gross Yield 1.18%
Cash Dividend (CHF) 0.2000
Dividend Ex-Date 03/28/2014
5 Year Dividend Growth -18.32%
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOBN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NOBN

Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.

Richard T LaubeChief Executive OfficerOliver WalkerChief Financial Officer
Hans GeiselhoringerExec VP:Global ResearchMelker NilssonExec VP:Global Customer
More Company Profile & Key Executives for NOBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil